Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsOPHTHALMICGeneric

STATROL

NEOMYCIN SULFATE; POLYMYXIN B SULFATE

Standard Dose
EQ 3.5MG BASE/ML;16,250 UNITS/ML
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary

Approval overview STATROL is listed in Drugs@FDA under application 062339 (ANDA).

Marketing status: Discontinued Active ingredient NEOMYCIN SULFATE; POLYMYXIN B SULFATE Form and strength SOLUTION/DROPS;OPHTHALMIC - EQ 3.5MG BASE/ML;16,250 UNITS/ML Sponsor ALCON Submission history Latest submission status date: 1995-08-04 00:00:00.

Structured Monograph

Clinical summary

Approval overview STATROL is listed in Drugs@FDA under application 062339 (ANDA). Marketing status: Discontinued Active ingredient NEOMYCIN SULFATE; POLYMYXIN B SULFATE Form and strength SOLUTION/DROPS;OPHTHALMIC - EQ 3.5MG BASE/ML;16,250 UNITS/ML Sponsor ALCON Submission history Latest submission status date: 1995-08-04 00:00:00. Submission type: SUPPL.

Monitoring

  • • Review priority: STANDARD
  • • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.